secwatch.observer — SEC 8-K summary
======================================

Issuer:     NUVASIVE INC (—)
CIK:        0001142596
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0001193125-23-140714
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.02, 2.03, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NuVasive Q1 net sales $307.7M (+5.8% YoY) posts GAAP loss; reaffirms FY guidance
--------------------------------------------------------------------------------

- Q1 net sales $307.7M, +5.8% as reported, +7.7% constant currency; U.S. cervical growth >20% sixth straight quarter.
- GAAP net loss $1.0M ($0.02 diluted loss per share); non-GAAP net income $24.8M, $0.47 EPS vs $0.54 prior year.
- Full-year 2023 net sales growth guidance reaffirmed at 6%-8% as reported and constant currency.
- Amended credit agreement from LIBOR to SOFR; intends to draw $550M facility to repay $450M convertible notes due June 2023.
- CAO Marc Rosenbaum resigns effective May 19; CFO Matthew Harbaugh will assume CAO duties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1142596/000119312523140714/0001193125-23-140714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1142596/000119312523140714/d423091d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-140714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer